We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HCAC
576
Hall Chadwick Acquisition Corp
HCAC
$295M
| $16.3M | 0.02% |
1,620,000
| – | – |
|
577
Zura Bio
ZURA
$547M
| $16.2M | 0.02% |
2,750,000
| – | – |
|
578
Community Bank
CBU
$3.28B
| $15.9M | 0.02% |
236,766
+160,000
| +208% | +$10.1M |
|
|
ALH
579
Alliance Laundry Holdings
ALH
$4.32B
| $15.8M | 0.02% |
594,771
-629,004
| -51% | -$15.7M |
|
|
KRSP
580
Rice Acquisition Corporation 3
KRSP
$485M
| $15.8M | 0.02% |
1,500,000
| – | – |
|
|
NHIV
581
NewHold Investment Corp IV
NHIV
$277M
| $15.8M | 0.02% |
+1,575,000
| New | +$15.8M |
|
|
DNMX
582
Dynamix Corp III
DNMX
$270M
| $15.7M | 0.02% |
1,575,000
| – | – |
|
|
VHCP
583
Vine Hill Capital Investment Corp II
VHCP
$310M
| $15.7M | 0.02% |
1,575,000
| – | – |
|
584
Veeva Systems
VEEV
$42.2B
| $15.7M | 0.02% |
+88,463
| New | +$14.6M |
|
585
Planet Fitness
PLNT
$3.77B
| $15.7M | 0.02% |
+300,000
| New | +$17.6M |
|
|
MUZE
586
Muzero Acquisition Corp
MUZE
$273M
| $15.6M | 0.02% |
1,575,000
| – | – |
|
587
Markel Group
MKL
$22.1B
| $15.6M | 0.02% |
+8,000
| New | +$14.9M |
|
588
Atlassian
TEAM
$45B
| $15.6M | 0.02% |
200,000
| – | – |
|
589
Arch Capital
ACGL
$32.8B
| $15.5M | 0.02% |
160,100
-35,100
| -18% | -$3.31M |
|
590
Cavco Industries
CVCO
$4.14B
| $15.4M | 0.02% |
25,000
-17,035
| -41% | -$9.04M |
|
|
EVAC
591
EQV Ventures Acquisition Corp II
EVAC
$602M
| $15.3M | 0.02% |
1,500,000
| – | – |
|
592
Ocular Therapeutix
OCUL
$2.52B
| $15.2M | 0.02% |
+1,550,000
| New | +$14M |
|
593
Constellation Brands
STZ
$20.8B
| $15.2M | 0.02% |
109,267
+84,000
| +332% | +$12.5M |
|
594
HBT Financial
HBT
$1.31B
| $15.1M | 0.02% |
473,202
+27,422
| +6% | +$788K |
|
595
Solid Biosciences
SLDB
$1.02B
| $15M | 0.02% |
1,506,506
-250,000
| -14% | -$1.9M |
|
596
Global Payments
GPN
$23B
| $15M | 0.02% |
207,160
-5,100
| -2% | -$351K |
|
597
Estee Lauder
EL
$35.7B
| $15M | 0.02% |
190,384
-30,200
| -14% | -$2.44M |
|
598
Biohaven
BHVN
$2.27B
| $14.9M | 0.02% |
1,000,000
-497,793
| -33% | -$5.36M |
|
|
FBRX
599
DELISTED
Forte Biosciences
FBRX
| $14.9M | 0.02% |
700,000
-250,000
| -26% | -$5.93M |
|
600
Mammoth Energy Services
TUSK
$153M
| $14.9M | 0.02% |
4,575,000
| – | – |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.